# US 2026/0306814 A1 · Precision administration of ultra-loaded injectable nanocarriers

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0306814 A1
- Document ID: US20260306814A1
- Status: Published application
- Kind: A1
- Application number: 19/552,372
- Filed: 2026-02-27
- Published: 2026-10-08
- Earliest claimed: 2025-02-27
- Assignees: Massachusetts Institute of Technology; The Brigham and Women's Hospital, Inc.
- Applicants: Massachusetts Institute of Technology; The Brigham and Women's Hospital, Inc.
- Inventors: Carlo Giovanni Traverso; Jason Siu-Wei Li; Seungho Lee; Will Tritschler; Nabil Shalabi; Yogesh Deshpande; Cooper Konz
- Web page: https://patentgrep.com/patent/US20260306814A1

## CPC

- A61M 37/0015: {by using microneedles}
- A61M 2037/0023: {Drug applicators using microneedles}
- A61M 2205/21: insensitive to tilting or inclination, e.g. spill-over prevention
- A61M 2205/8281: spring operated
- A61M 2210/1053: Stomach
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

Self-righting articles, such as self-righting capsules for administration to a subject, are generally provided. In some embodiments, the self-righting article is configured to orient itself relative to a surface, e.g., along a tissue engaging surface. In some embodiments, the self-righting article has a particular shape and/or distribution of density (or mass) that enables the self-righting behavior of the article. In some embodiments, the self-righting article comprises a tissue interfacing component and/or a pharmaceutical agent. In some embodiments, the self-righting article is configured to release one or more tissue interfacing components.

## Claims

### Claim 1

A self-righting article, comprising:
(i) a tissue-engaging surface;
(ii) one or more curved surfaces adjacent the tissue-engaging surface;
(iii) a drug-containing portion, wherein the drug-containing portion occupies greater than or equal to 30 vol % of the self-righting article and/or the drug-containing portion comprises greater than or equal to 250 uL of drug;
(iv) a tissue interfacing component;
(v) an actuation mechanism configured to actuate horizontally with respect to a major axis of the tissue-engaging surface; and
(vi) one or more springs, where at least one spring is operably linked to the actuation mechanism and/or the tissue interfacing component.

### Claim at position 2

2-3. (canceled)

### Claim 4

A self-righting article, comprising:
(i) one or more curved surfaces adjacent a tissue-engaging surface;
(ii) a drug-containing portion, wherein the drug-containing portion comprises greater than or equal to 250 uL of drug;
(iv) a liquid jet injection component;
(iv) an actuation mechanism configured to actuate horizontally with respect to a major axis of the tissue-engaging surface; and
(vi) one or more springs, where at least one spring is operably linked to the actuation mechanism and/or the jet injection component.

### Claim 5 (depends on 1)

The article as in claim 1, further comprising a reservoir comprising the drug-containing portion.

### Claim 6 (depends on 1)

The article as in claim 1, wherein the drug-containing portion comprises a liquid active pharmaceutical agent or a solid active pharmaceutical agent.

### Claim 7

(canceled)

### Claim 8 (depends on 1)

The article as in claim 1, wherein the tissue interfacing component is operably linked to the actuation mechanism.

### Claim 9 (depends on 1)

The article as in claim 1, wherein when the self-righting article is oriented in a longitudinal orientation relative to an external surface:
a center of mass of the self-righting article is offset from a first axis that is perpendicular to the tissue-engaging surface, wherein the first axis passes through the center of curvature of the one or more curved surfaces, and
wherein the article rotates toward the center of mass until the tissue-engaging surface contacts the external surface.

### Claim 10

A self-righting article, the self-righting article comprising:
an outer shell;
an active pharmaceutical ingredient disposed within the outer shell configured for delivery to a location internal to a subject;
the outer shell comprising:
i) a flat surface;
ii) a lateral monostable cross-section; and
iii) a longitudinal, bistable, cross-section,
such that the outer shell reorients such that the flat surface contacts a surface, regardless of an initial orientation of the self-righting article.

### Claim 11 (depends on 1)

The article as in claim 1, wherein the drug-containing portion comprises a plurality of tissue interfacing components.

### Claim 12 (depends on 1)

The article as in claim 1, wherein a first spring is configured to displace the tissue interfacing component and a second spring is configured to displace a liquid active pharmaceutical agent.

### Claim 13 (depends on 1)

The article as in claim 1, wherein:
a first actuation mechanism comprises:
(i) a first spring and a first support material adapted to maintain the first spring in at least a partially compressed state, wherein the first support material is configured for at least partial degradation in a biological fluid; and
a second actuation mechanism comprises:
(ii) a second spring and a second support material adapted to maintain the second spring in at least a partially compressed state, wherein the second support material is configured for at least partial degradation in a biological fluid.

### Claim at position 13

14-15. (canceled)

### Claim 16 (depends on 1)

The article as in claim 1, wherein the tissue interfacing component forms or comprises an injection needle operably linked to a first spring component, wherein the first spring component is operable from a first configuration to a second configuration upon at least partial degradation of a support material, wherein the injection needle is retained within the article when the first spring component is in the first configuration, and wherein the injection needle is configured to be advanced from the article and into a lumen wall by movement of the first spring component from the first configuration to the second configuration.

### Claim 17 (depends on 1)

The article as in claim 1, wherein an injection needle comprises a tissue penetration end, a second end portion opposite the tissue penetrating end, and a side wall extending between the tissue penetrating end and the second end portion, the side wall comprising a side hole disposed such that, when a first spring component is in a second configuration, fluid communication is established between a reservoir and the tissue penetration end of the injection needle.

### Claim 18 (depends on 1)

The article as in claim 1, wherein a reservoir and a tissue penetration end of an injection needle are not in fluidic communication when a first spring is in a first configuration.

### Claim 19 (depends on 1)

The article as in claim 1, wherein a reservoir further comprises an end wall arranged opposite a movable wall, wherein the end wall comprises a channel, and wherein, when a first spring component assumes a first configuration, a injection needle side hole is positioned above said channel, and wherein, when a first spring component assumes a second configuration, an injection needle side hole is positioned within said channel.

### Claim 20 (depends on 1)

The article as in claim 1, wherein the actuation mechanism comprises a second spring component held releasably in a compressed state, the second spring component being configured to release from the compressed state, upon a first spring component moving from a first configuration into a second configuration, to drive a movable wall to expel liquid active pharmaceutical agent from a reservoir into an end wall channel and into an injection needle side hole.

### Claim 21 (depends on 1)

The article as in claim 1, wherein the actuation mechanism comprises a self-actuating component comprising a movable microneedle hub within a reservoir, the movable microneedle hub comprising:
a plurality of spring components and a plurality of support material adapted to maintain the plurality of spring components in at least a partially compressed state, wherein the plurality of support material is configured for at least partial degradation in a biological fluid.

### Claim 22 (depends on 1)

The article as in claim 1, wherein a movable microneedle hub comprises a plurality of microneedles, and is operably linked to a plurality of spring components, wherein the plurality of spring components is operable from a first configuration to a second configuration upon at least partial degradation of a support material, wherein the plurality of microneedles is retained within the article when the plurality of spring components is in the first configuration, and wherein the plurality of microneedles is configured to be advanced from the article and into a lumen wall by movement of the plurality of spring components from the first configuration to the second configuration.

### Claim at position 21

23-26. (canceled)

### Claim 27 (depends on 1)

The article as in claim 1, wherein when the self-righting article is oriented in a longitudinal orientation relative to an external surface:
a center of mass of the self-righting article is offset from a first axis that passes through a point of contact with an external surface and is parallel to a vector of a gravitational force, wherein the article rotates toward the center of mass until the tissue-engaging surface contacts the external surface.

### Claim 28

(canceled)
